Related Experiment Videos
eIF4A3 is a novel component of the exon junction complex
Chia C Chan1, Josee Dostie, Michael D Diem
1Howard Hughes Medical Institute and Department of Biochemistry & Biophysics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6148, USA.
RNA (New York, N.Y.)
|January 20, 2004
Summary
The exon junction complex (EJC) includes eIF4A3, a novel RNA helicase. This finding suggests splicing influences mRNA translation through EJC-bound eIF4A3 in the nucleus.
Area of Science:
- Molecular Biology
- RNA Biology
- Gene Expression
Background:
- The exon junction complex (EJC) is crucial for post-splicing mRNA processing.
- Evidence indicates splicing history impacts mRNA translation.
- The precise mechanisms linking splicing to translation remain under investigation.
Purpose of the Study:
- To identify novel components of the EJC.
- To investigate the role of translation initiation factors in EJC function.
- To determine if splicing influences mRNA translation via EJC components.
Main Methods:
- Co-immunoprecipitation assays to identify protein interactions.
- Analysis of mRNA association with EJC components.
- In vitro splicing assays.
- Subcellular localization studies using monoclonal antibodies.
Main Results:
- eIF4A3, a DEAD-box RNA helicase, was identified as a novel EJC component.
- eIF4A3 preferentially binds to spliced mRNAs and nuclear EJC complexes containing magoh and Y14.
- Unlike eIF4A1 and eIF4A2, eIF4A3 is localized to the nucleus.
- eIF4A3 binds mRNA at the EJC position.
Conclusions:
- eIF4A3 is a nuclear EJC component that binds spliced mRNA.
- The localization and binding preference of eIF4A3 suggest a role in mediating splicing-dependent translational control.
- This discovery provides a molecular link between mRNA splicing and translation initiation.